<?xml version="1.0" encoding="UTF-8"?>
<urlset
      xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
      xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
      xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9
            http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
<!-- created with Free Online Sitemap Generator www.xml-sitemaps.com -->


<url>
  <loc>http://www.neumohula.es/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>1.00</priority>
</url>
<url>
  <loc>http://www.neumohula.es/noticias/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/personal-medico/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/publicaciones-2/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/presentaciones-congresos/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/ensayos-clinicos-y-estudios-2/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/cartera-de-servicios-2/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/acta-del-servicio/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/galeria-de-fotos/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/contacto/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/personal-enfermeria/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Efficacy-and-Safety-of-treatment-with-dupilumab-for-severe-asthma/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/RIBRON-The-spanish-Online-Bronchiectasis-Registry-Characterization-of-the-First-1912-Patients/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Efficacy-and-safety-of-treatment-with-biologicals-benralizumab-dupilumab-and-omalizumab-for-severe-allergic-asthma/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Articulo-de-Prensa/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Letalidad-del-COVID-19-por-Provincias/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Lorem-ipsum-dolor-sit-amet-consectetur-adipiscing-elit/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Characterization-of-Eosinophilic-And-Non-eosinophilic-Severe-Asthma-Phenotypes-And-Proportion-of-Patients-with-These-Phenotypes-In-The-International-Severe-Asthma-Registry-ISAR-/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Reunion-del-PII-de-asma/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Reunion-de-invierno-conjunta-areas-SEPAR-Malaga/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Estudio-multicentrico-2/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Estudio-multicentrico/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Carga-de-la-enfermedad-en-pacientes-con-EPOC-eosinofilica-en-Espana-Estudio-observacional-multicentrico/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/cookies/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/politica-de-privacidad/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Articulo-en-el-Progreso/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Entrevista-en-el-Progreso-a-Luis-Perez-del-Llano-jefe-Neumologia/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/archivos/fichas/luisperezdellanoactualizado-29.pdf</loc>
  <lastmod>2020-05-15T09:41:35+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/archivos/fichas/ALEJANDROVERES-16-23.pdf</loc>
  <lastmod>2020-05-15T09:41:32+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/archivos/fichas/rafael-golpe-gomez-22.pdf</loc>
  <lastmod>2020-05-15T09:41:37+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/archivos/fichas/nagore-blanco-cid-21.pdf</loc>
  <lastmod>2020-05-15T09:41:37+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/archivos/fichas/CV-6-24.pdf</loc>
  <lastmod>2020-05-15T09:41:33+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/archivos/fichas/CV-BREVE-7-19-25.pdf</loc>
  <lastmod>2020-05-15T09:41:33+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/archivos/fichas/CV-para-NML-HULA-10-26.pdf</loc>
  <lastmod>2020-05-15T09:41:33+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/archivos/fichas/CV-Olalla-Castro-Anon-8-15.pdf</loc>
  <lastmod>2020-05-15T09:41:33+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Efficacy-and-safety-of-treatment-with-biologicals-benralizumab-dupilumab-mepolizumab-omalizumab-and-reslizumab-for-severe-eosinophilic-asthma/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Publicacion/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Plasma-Eosinophil-Count-and-Patient-Centered-Events-in-Chronic-Obstructive-Pulmonary-Disease-in-Real-Life-Clinical-Practice/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/publicaciones-2/pagina/1/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/publicaciones-2/pagina/2/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/publicaciones-2/pagina/3/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Exacerbaciones-graves-en-EPOC-por-tabaco-y-por-humo-de-biomasa/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Capacidad-de-diversas-variables-funcionales-para-predecir-mortalidad-en-la-EPOC/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Asma-da-urg%C3%AAncia-a-consulta-Terap%C3%AAutica-Biologica/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/presentaciones-congresos/pagina/1/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/presentaciones-congresos/pagina/2/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/presentaciones-congresos/pagina/3/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/presentaciones-congresos/pagina/4/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Estudio-transversal-para-conocer-las-necesidades-clinicas-no-cubiertas-en-Asma-grave/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Estudio-observacional-multicentrico-%E2%80%9CCarga-de-la-enfermedad-en-pacientes-con-EPOC-eosinofilica-en-Espana%E2%80%9D-HO-16-16447/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Estudio-piloto-de-reslizumab-en-pacientes-con-asma-grave-que-no-han-respondido-a-omalizumab%E2%80%9D-SEP-RES-2016-01-SEP078020-/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/ensayos-clinicos-y-estudios-2/pagina/1/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/ensayos-clinicos-y-estudios-2/pagina/2/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/galeria-de-fotos/pagina/1/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/archivos/fichas/Maria-del-Carmen-Gomez-Neira-11-27.pdf</loc>
  <lastmod>2020-05-15T09:41:35+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Asthma-Attacks-and-Cardiovascular-Events-Earthquakes-and-Tsunamis/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/International-Severe-Asthma-Registry-Mission-Statement/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Can-the-COPD-comorbidome-Be-Applied-to-All-Outpatients-With-Chronic-Obstructive-Pulmonary-Disease-A-Single-center-Analysis/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Mepolizumab-and-reslizumab-two-different-options-for-severe-asthma-patients-with-prior-failure-to-omalizumab/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Efficacy-and-Safety-of-Reslizumab-in-Patients-with-Severe-Asthma-with-Inadequate-Response-to-Omalizumab-A-Multicenter-Open-Label-Pilot-Study/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Should-Lung-Function-Be-Included-in-the-Risk-Stratification-of-Chronic-Obstructive-Pulmonary-Disease-Proposed-by-GesEPOC/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Comparison-of-the-prognostic-capability-of-two-comorbidity-indices-in-patients-with-chronic-obstructive-pulmonary-disease-in-real-life-clinical-practice/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Unmet-therapeutic-goals-and-potential-treatable-traits-in-a-population-of-patients-with-severe-uncontrolled-asthma-in-Spain-ENEAS-study/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/A-Simple-Score-for-Future-Risk-Prediction-in-Patients-with-Controlled-Asthma-Who-Undergo-a-Guidelines-Based-Step-Down-Strategy/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Asthma-COPD-overlap-identification-and-optimal-treatment/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Lung-cancer-and-residential-radon-in-never-smokers-A-pooling-study-in-the-Northwest-of-Spain/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Residential-radon-genetic-polymorphisms-in-DNA-damage-and-repair-related/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Lung-cancer-risk-and-do-it-yourself-activities-A-neglected-risk-factor-for-lung-cancer/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Avalia%C3%A7%C3%A3o-da-resposta-terap%C3%AAutica-biologica-e-criterios-de-switch/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Airway-diseases-and-blood-cells/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Can-a-reduction-in-risk-lead-to-an-improvement-in-asthma-control/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Congreso-SEPAR-2019-S154-Retos-diagnosticos-y-terapeuticos-en-la-practica-clinica-de-los-pacientes-con-hipertension-pulmonar/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Variabilidad-de-los-sintomas-y-su-relacion-con-el-control-clinico-en-EPOC-resultados-del-estudio-VASICO/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Valor-pronostico-de-nuevas-variables-derivadas-del-test-de-la-marcha-de-6-minutos-en-EPOC/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Distribucion-de-los-casos-de-gripe-en-el-area-de-Lugo-en-las-7-ultimas-temporadas/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/OBJETIVOS-TERAPEUTICOS-Y-CARACTERISTICAS-TRATABLES-EN-UNA-POBLACION-DE-PACIENTES-CON-ASMA-GRAVE-NO-CONTROLADA-EN-ESPANA-ESTUDIO-ENEAS/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/EFICACIA-Y-SEGURIDAD-DEL-RESLIZUMAB-EN-PACIENTES-CON-ASMA-GRAVE-Y-RESPUESTA-INADECUADA-AL-OMALIZUMAB-ESTUDIO-PILOTO-ABIERTO-Y-MULTICENTRICO/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Maximizing-the-first-international-severe-asthma-registry-for-research-New-tools/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/European-Respiratory-Society-Congress-2020-submitted-2/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Evaluacion-del-estado-de-riesgo-en-pacientes-con-hipertension-arterial-pulmonar-en-Espana-estudio-observacional-SEMAFORO-Area-Circulacion-pulmonar/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Reunion-de-Invierno-de-la-SEPAR-2020/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/P109-The-effect-of-pleural-fluid-on-survival-in-patients-with-a-malignant-pleural-effusion/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/P104-Computed-tomography-evidence-of-lymphangitis-associated-to-malignant-pleural-effusion-its-prevalence-and-impact-on-survival/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/British-Thoracic-Society-Winter-Meeting-2019-Novel-insights-into-malignant-pleural-disease-2/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/presentaciones-congresos/pagina/5/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/British-Thoracic-Society-Winter-Meeting-2019-Novel-insights-into-malignant-pleural-disease/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Session-397-Poster-discussion-Biology-of-lung-cancer/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/European-Respiratory-Society-Congress-2020/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/European-Respiratory-Society-Congress-2019OA492/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/European-Respiratory-Society-Congress-2019/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Estudio-multicentrico-aleatorio-doble-ciego-controlado-con-placebo-de-52-semanas-de-duracion-para-evaluar-la-eficacia-y-la-seguridad-de-QAW039-anadido-a-tratamiento-existente-para-el-asma-en-pacientes-con-asma-grave-no-controlada/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Estudio-fase-IV-observacional-multinacional-sobre-el-control-de-la-enfermedad-y-los-resultados-notificados-por-los-pacientes-en-tratamiento-con-inhaladores-de-combinacion-a-dosis-fija-para-asma-persistente-y-EPOC-en-la-practica-habitual-SPRINT-/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Valoracion-del-cambio-en-el-control-clinico-frente-al-cambio-en-el-nivel-de-gravedad-en-pacientes-con-EPOC/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Ensayo-Clinico-fase-III-multicentrico-aleatorizado-doble-ciego-con-grupos-paralelos-y-controlado-con-placebo-para-evaluar-la-eficacia-y-la-seguridad-de-Benzalizumab/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Estudio-de-investigacion-Eficacia-de-una-estrategia-simple-para-promover-el-cumplimiento-terapeutico-SMARTRACK-/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Estudio-de-Desarrollo-de-una-regla-de-prediccion-para-estimar-el-riesgo-futuro-en-pacientes-con-asma-controlada-a-los-que-se-reducira-el-tratamiento-segun-una-estrategia-basada-en-las-guias-de-practica-clinica-Fase-de-derivacion-de-la-regla-EPRAC-/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Estudio-ECO/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/Ensayo-Clinico-205452-TIOSPIR/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>http://www.neumohula.es/EXACERBACIONES-GRAVES-EN-EPOC-POR-TABACO-Y-POR-HUMO-DE-BIOMASA-2/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.41</priority>
</url>
<url>
  <loc>http://www.neumohula.es/CAPACIDAD-DE-DIVERSAS-VARIABLES-FUNCIONALES-PARA-PREDECIR-MORTALIDAD-EN-LA-EPOC-2/</loc>
  <lastmod>2020-05-15T11:24:22+00:00</lastmod>
  <priority>0.41</priority>
</url>


</urlset>